| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.15 | 4e-05 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.19 | 0.0001 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | -0.19 | 0.0002 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0003 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0003 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0004 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.0006 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0008 |